Physician profile
Peipei Zhou
NPI 1336134709
$1,683.20
in general payments reported to CMS, 2019-2025
16 companies · $79.96 in 2025
The $79.96 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $157 · 2020: $157 · 2021: $306 · 2022: $357 · 2023: $314 · 2024: $311 · 2025: $79.96.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $705.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $705.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $392.43 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $257.24 | 2021-2023 | Verquvo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $250.71 | 2019-2025 | Jardiance |
| Janssen Pharmaceuticals, INC | $162.73 | 2019-2022 | |
| Amarin Pharma, INC. | $106.34 | 2020-2021 | |
| Actelion Pharmaceuticals US, INC. | $90.46 | 2023-2024 | Uptravi, Opsumit |
| Amgen INC. | $83.81 | 2024 | Repatha |
| Cvrx, INC. | $57.98 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $52.63 | 2019-2022 | |
| Pfizer INC. | $51.17 | 2022-2023 | |
| E.R. Squibb & Sons, L.L.C. | $49.76 | 2020-2024 | Eliquis, Camzyos |
| Scpharmaceuticals INC. | $48.26 | 2023-2025 | |
| Novo Nordisk INC | $22.13 | 2021 | |
| Sanofi-Aventis U.S. LLC | $19.99 | 2019 | |
| Boston Scientific Corporation | $18.90 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $18.66 | 2023 | Impella |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peipei Zhou listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.